CHI3L1 and metabolic dysfunction-associated steatotic liver disease: Our observation needs to be validated in large independent cohorts such as the RESOLVE-IT [26] or the European NAFLD registry longitudinal cohort [27] in which candidates such as PRO-C3, YKL-40, A2M have recently been tested [8,22].